Cytek Biosciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US23285D1090
USD
5.20
-0.19 (-3.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
395.74
393.06
425.30
405.04
178.29
32.95
Shareholder's Funds
395.74
393.06
425.30
405.04
178.29
32.95
Minority Interest
0.00
0.00
0.25
0.34
0.00
0.00
Long-Term Borrowings
20.20
23.70
23.54
0.00
2.77
0.00
Secured Loans
20.20
23.70
23.54
0.00
2.77
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-33.37
-30.49
-20.46
-9.17
-7.38
0.00
Other Long Term Liabilities
28.59
30.25
31.07
25.52
15.56
17
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
38.68
48.38
48.94
25.52
15.56
17.00
Current Liabilities
Trade Payables
5.53
3.03
4.80
3.03
2.94
2.34
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
67.66
56.23
49.04
33.18
26.54
21.04
Total Liabilities
502.08
497.67
523.52
464.08
220.38
70.99
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
36.84
35.18
30.72
7.71
3.07
1.44
Less: Accumulated Depreciation
8.71
5.92
3.16
1.86
0.93
0.40
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
28.13
29.26
27.57
5.85
2.14
1.04
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
1.60
1.60
1.60
0.00
0.00
0.25
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
3.16
1.78
1.36
1.67
1.09
0.57
Total Non-Current Assets
105.63
105.61
69.50
32.35
11.76
3.22
Current Assets Loans & Advances
Current Investments
179.15
95.11
44.55
0.00
0.00
0.00
Inventories
43.89
60.88
48.15
32.17
23.02
18.43
Sundry Debtors
60.59
55.93
48.86
29.76
16.99
17.15
Cash and Bank
98.75
167.63
299.50
364.62
166.12
30.24
Other Current Assets
382.37
379.74
443.08
426.42
207.24
66.42
Short Term Loans and Advances
0.00
0.19
2.01
-0.13
1.11
0.60
Total Current Assets
396.45
392.06
454.02
431.73
208.62
67.77
Net Current Assets (Including Current Investments)
328.78
335.83
404.98
398.55
182.09
46.73
Total Current Assets Excluding Current Investments
396.45
392.06
454.02
431.73
208.62
67.77
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
502.08
497.67
523.52
464.08
220.38
70.99
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
20.20
23.70
23.54
0.00
2.77
0.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Cytek Biosciences, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
395.74
354.57
41.17
11.61%
Shareholder's Funds
395.74
354.57
41.17
11.61%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
20.20
79.03
-58.83
-74.44%
Secured Loans
20.20
79.03
-58.83
-74.44%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-33.37
3.38
-36.75
-1,087.28%
Other Long Term Liabilities
28.59
19.77
8.82
44.61%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
38.68
95.17
-56.49
-59.36%
Current Liabilities
Trade Payables
5.53
8.91
-3.38
-37.93%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
67.66
33.96
33.70
99.23%
Total Liabilities
502.08
483.70
18.38
3.80%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
36.84
104.95
-68.11
-64.90%
Less: Accumulated Depreciation
8.71
46.12
-37.41
-81.11%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
28.13
58.83
-30.70
-52.18%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
1.60
2.18
-0.58
-26.61%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
3.16
0
3.16
0.00%
Total Non-Current Assets
105.63
246.53
-140.90
-57.15%
Current Assets Loans & Advances
Current Investments
179.15
25.01
154.14
616.31%
Inventories
43.89
117.00
-73.11
-62.49%
Sundry Debtors
60.59
42.36
18.23
43.04%
Cash and Bank
98.75
45.78
52.97
115.71%
Other Current Assets
382.37
230.15
152.22
66.14%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
396.45
237.17
159.28
67.16%
Net Current Assets (Including Current Investments)
328.78
203.21
125.57
61.79%
Total Current Assets Excluding Current Investments
396.45
237.17
159.28
67.16%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
502.08
483.70
18.38
3.80%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
20.20
79.03
-58.83
-74.44%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period